Manage your personalised Watchlist.Set up an online Virtual Portfolio.Participate in Share Chat.See more trades and director dealings.Play the Fantasy Share Trading Game.
Register for FREE Now
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.
Joy13
Posted in: OPTI
Posts: 1,341
Price: 59.50
No Opinion
I see on the Nasdaq index there’s a company called Silverback Therapeutics listed under the trading reference of SBTX ! That could cause confusion....
Price: 48.50
£97,000+ shares sold and £216,000+ bought! Yet the s/p has dropped 6%....
Price: 55.50
Someone’s confident paying over the odds, 57.50 paid for a £20,000 stake In Opti. I’m still holding, great RNS’s been reported lately, looking very promising.
Price: 49.00
Just noticed the £110.24k trade that went through on Friday, Pity it hasn’t moved the share price up. Wonder if it was an institution ?
Price: 52.50
https://youtu.be/Xv2KZXxp4_c
Price: 66.50
Great RNS, distribution USA & Canada.
Price: 55.00
Sorry if article can’t be opened.
Subject: Product launches indicate growing momentum for year aheadhttps://*********************/NoteArticle/Article?researchnoteid=5ed6a932-3f72-49fe-b3dd-37787327e7ab
Front window display at our local store here in Liverpool today
Price: 57.00
Only 1 RNS today
Price: 58.50
Subject: SlimBiome® distribution agreement for Germany - RNS - London Stock Exchange?https://www.londonstockexchange.com/exchange/news/market-news/market-news-detail/OPTI/14355189.html
Price: 52.00
Thank you
Didn’t we receive a half year report this time last year, and idea when one is due?
Price: 53.00
Meant to thank Elrico, thanks for podcast.
Thanks for the Podcast last week with SOH, much appreciated. sounds very promising.
Price: 64.50
Can’t believe we didn’t have a single trade today!
Thanks Elrico, much appreciated .
Price: 17.00
After hours...
Price: 91.50
Great RNS Monday regarding Imperial College.
Price: 58.00
Latest report from researchtree reiterating share price should be 97phttps://*********************/companies/uk/biotechnology/optibiotix-health/research/goetzpartners-securities-limited/lp-ldl-achieves-two-major-milestones/db0b8540-57fe-4a36-9761-3a5760797546
Login failed